https://charts.traderzeitung.de/phases/CA00288U1066
string(1518) "{"isin":"CA00288U1066","name":"AbCellera Biologics Inc","stock_id_xnas":16776055,"stock_id_xnys":null,"generated_at":"2026-08-09 08:04:00","days":[{"date":"2026-08-05","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":6.045,"close_at":"2026-08-05 15:28:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":5.935,"close_at":"2026-08-05 21:59:00","complete":true,"perf_pct":-1.8197},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":5.75,"close_at":"2026-08-06 01:00:00","complete":true,"perf_pct":-3.1171}]},{"date":"2026-08-06","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":5.7,"close_at":"2026-08-06 15:27:00","complete":true,"perf_pct":-0.8696},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":6.525,"close_at":"2026-08-06 21:59:00","complete":true,"perf_pct":14.4737},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":6.48,"close_at":"2026-08-07 01:42:00","complete":true,"perf_pct":-0.6897}]},{"date":"2026-08-07","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":6.64,"close_at":"2026-08-07 15:29:00","complete":true,"perf_pct":2.4691},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":6.94,"close_at":"2026-08-07 21:59:00","complete":true,"perf_pct":4.5181},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":7.49,"close_at":"2026-08-07 23:57:00","complete":true,"perf_pct":7.9251}]}]}"
AbCellera Biologics
Trading-Room

AbCellera Biologics Aktie News & Nachrichten

[WKN: A2QKXS | Symbol: ABCL]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über AbCellera Biologics gefunden werden.

AbCellera Biologics Nachrichtenticker öffnen
MT Newswires 05.08.2026 23:20 Uhr

-- Earnings Flash (ABCL) AbCellera Biologics Inc. Meldet Q2-Umsatz von 4,1 Mio. $

04:47 PM EDT, 08/05/2026 (MT Newswires) -- http://www.mtnewswires.com Copyright © 2026 MT Newswires. All rights reserved. MT Newswires does not provid

MT Newswires 07.07.2026 13:34 Uhr

Benchmark stuft AbCellera Biologics von Halten auf Kaufen hoch, Kursziel ist $11

07:33 AM EDT, 07/07/2026 (MT Newswires) -- AbCellera Biologics (ABCL) hat eine durchschnittliche Bewertung von Kaufen und ein mittleres Kursziel von $

MT Newswires 17.06.2026 15:16 Uhr

Börsengehandelte Fonds höher, Aktien-Futures uneinheitlich vorbörslich am Mittwoch vor der Zinsbekanntgabe der Fed

09:15 AM EDT, 06/17/2026 (MT Newswires) -- Der breit aufgestellte börsengehandelte Fonds SPDR S&P 500 ETF Trust (SPY) stieg um 0,1 % und der aktiv

MT Newswires 17.06.2026 15:14 Uhr

Sektor-Update: Gesundheitsaktien am Mittwoch vorbörslich uneinheitlich

09:13 AM EDT, 06/17/2026 (MT Newswires) -- Gesundheitsaktien zeigten sich am Mittwoch vorbörslich uneinheitlich, wobei der State Street Health Care Se

MT Newswires 17.06.2026 13:38 Uhr

Jazz Pharmaceuticals, AbCellera Biologics kooperieren bei T-Zell-bindenden multispezifischen Antikörpern

07:37 AM EDT, 06/17/2026 (MT Newswires) -- Jazz Pharmaceuticals (JAZZ) und AbCellera Biologics (ABCL) unterzeichneten eine präklinische Forschungs-, O